Press Release⚠ 1
AbCellera Biologics Announces New AI Platform to Accelerate Innovation
The Newswire•5h ago
AB
AbCellera Biologics Inc.
Nasdaq : ABCLHealthcare · Pharmaceutical Preparations
Mkt Cap$4.09BShares Out306.61M30d Avg Vol26.61MShort Int—Short Float—IPODec 11, 2020
▼-3.18%
$23.42
Press Release
AbCellera Biologics Unveils Flagship System Delivering World-Class AI Performance
GlobeNewswire•2d ago
News
Analysts at ETF Trends raise AbCellera Biologics price target on strong demand
Doomberg•4d ago
Press Release
AbCellera Biologics Announces Developer Toolkit to Accelerate AI Workflows
The multi-year agreement covers phased deployment across the partner's global footprint, operationalizing a prior memorandum of understanding and establishing AbCellera Biologics as a strategic technology partner at the core of the stack.
•6d ago
Press Release
AbCellera Biologics Unveils Vera-Class Platform Delivering Record AI Performance
More than 50 organizations are adopting the platform to accelerate complex workflows, leveraging AbCellera Biologics's accelerated computing stack to provide the context needed for real-world deployment at scale.
•6d ago
Press Release
GIGABYTE Accelerates Operations With Agentic AI Powered by AbCellera Biologics
Management reaffirmed full-year guidance and pointed to durable demand, citing continued strength across its core markets and a growing pipeline of enterprise customers standardizing on AbCellera Biologics.
•6d ago
News
Analysts at Semianalysis raise AbCellera Biologics price target on strong demand
The system delivers a step-change in performance for the most demanding workloads, with major partners scheduled to release compatible systems later this year as demand for AbCellera Biologics's platform continues to climb.
•7d ago
News
AbCellera Biologics tops revenue estimates; guidance tops Street view
Management reaffirmed full-year guidance and pointed to durable demand, citing continued strength across its core markets and a growing pipeline of enterprise customers standardizing on AbCellera Biologics.
•7d ago
Press Release
AbCellera Biologics Board Authorizes New $10B Share Repurchase Program
Management reaffirmed full-year guidance and pointed to durable demand, citing continued strength across its core markets and a growing pipeline of enterprise customers standardizing on AbCellera Biologics.
•7d ago
Press Release
Multiverse Computing Accelerates Operations With Agentic AI Powered by AbCellera Biologics
ACCESS Newswire•7d ago
Press Release
AbCellera Biologics Board Authorizes New $10B Share Repurchase Program
The system delivers a step-change in performance for the most demanding workloads, with major partners scheduled to release compatible systems later this year as demand for AbCellera Biologics's platform continues to climb.
•9d ago
Press Release
Eco Wave Power Acquires AbCellera Biologics Infrastructure With Contracted Customer Deployment
ACCESS Newswire•10d ago
News
AbCellera Biologics named a top pick as AI spending accelerates
Management reaffirmed full-year guidance and pointed to durable demand, citing continued strength across its core markets and a growing pipeline of enterprise customers standardizing on AbCellera Biologics.
•12d ago
News
Regulators weigh AbCellera Biologics's AI export exposure
Management reaffirmed full-year guidance and pointed to durable demand, citing continued strength across its core markets and a growing pipeline of enterprise customers standardizing on AbCellera Biologics.
•12d ago
Press Release
AbCellera Biologics Announces Developer Toolkit to Accelerate AI Workflows
The system delivers a step-change in performance for the most demanding workloads, with major partners scheduled to release compatible systems later this year as demand for AbCellera Biologics's platform continues to climb.
•14d ago
News
Regulators weigh AbCellera Biologics's AI export exposure
The system delivers a step-change in performance for the most demanding workloads, with major partners scheduled to release compatible systems later this year as demand for AbCellera Biologics's platform continues to climb.
•16d ago
News
AbCellera Biologics shares slip as investors weigh AI outlook
Calculated Risk•16d ago
Press Release
AbCellera Biologics Reports Record Quarterly Revenue, Raises Full-Year Guidance
The system delivers a step-change in performance for the most demanding workloads, with major partners scheduled to release compatible systems later this year as demand for AbCellera Biologics's platform continues to climb.
•16d ago
News
AbCellera Biologics shares slip as investors weigh AI outlook
The system delivers a step-change in performance for the most demanding workloads, with major partners scheduled to release compatible systems later this year as demand for AbCellera Biologics's platform continues to climb.
•16d ago
Press Release
Sigmatic Sciences Positions Its Stack as the Execution Layer for AI, Beginning With AbCellera Biologics
ACCESS Newswire•17d ago
Press Release
Multiverse Computing Accelerates Operations With Agentic AI Powered by AbCellera Biologics
PR Newswire•19d ago
News
Analysts at The Weekly ChartStorm raise AbCellera Biologics price target on strong demand
TechXplore•19d ago
Press Release
AbCellera Biologics Unveils Vera-Class Platform Delivering Record AI Performance
More than 50 organizations are adopting the platform to accelerate complex workflows, leveraging AbCellera Biologics's accelerated computing stack to provide the context needed for real-world deployment at scale.
•21d ago
Press Release
Rackspace Technology Deploys AbCellera Biologics Solutions Across Global Data Centers
PR Newswire•22d ago
Press Release
TensorX Turns Data Into Insight With AbCellera Biologics Infrastructure and Digital Twins
The multi-year agreement covers phased deployment across the partner's global footprint, operationalizing a prior memorandum of understanding and establishing AbCellera Biologics as a strategic technology partner at the core of the stack.
•22d ago
Press Release
AbCellera Biologics Announces New AI Platform to Accelerate Innovation
More than 50 organizations are adopting the platform to accelerate complex workflows, leveraging AbCellera Biologics's accelerated computing stack to provide the context needed for real-world deployment at scale.
•24d ago
Press Release
Rackspace Technology Turns Data Into Insight With AbCellera Biologics Infrastructure and Digital Twins
More than 50 organizations are adopting the platform to accelerate complex workflows, leveraging AbCellera Biologics's accelerated computing stack to provide the context needed for real-world deployment at scale.
•24d ago
Press Release
Rackspace Technology Deploys AbCellera Biologics Solutions Across Global Data Centers
GlobeNewswire•26d ago
Press Release
AbCellera Biologics Reports Record Quarterly Revenue, Raises Full-Year Guidance
The multi-year agreement covers phased deployment across the partner's global footprint, operationalizing a prior memorandum of understanding and establishing AbCellera Biologics as a strategic technology partner at the core of the stack.
•27d ago
Press Release
AbCellera Biologics Announces Developer Toolkit to Accelerate AI Workflows
The Newswire•28d ago
Press Release
Rackspace Technology Launches Next-Generation Platform in Collaboration With AbCellera Biologics
More than 50 organizations are adopting the platform to accelerate complex workflows, leveraging AbCellera Biologics's accelerated computing stack to provide the context needed for real-world deployment at scale.
•28d ago
Press Release
AbCellera Biologics to Present at Upcoming Investor Conference
Management reaffirmed full-year guidance and pointed to durable demand, citing continued strength across its core markets and a growing pipeline of enterprise customers standardizing on AbCellera Biologics.
•1mo ago
Press Release
AbCellera Biologics Highlights Supermicro's AI Breakthrough in New Corporate Blog
GlobeNewswire•1mo ago
Press Release
Supermicro Acquires AbCellera Biologics Infrastructure With Contracted Customer Deployment
PRISM MediaWire•1mo ago